Lung Cancer Clinical Trial
Metabolic and Microbial Profiling of Lung Cancer
Summary
This pilot study will establish non-invasive sample collections, including breath, saliva, blood and urine pre-surgery and at the participant's one-month post-surgery follow-up visit. Participants with suspected non-small cell lung cancer (NSCLC) stage I-III will be recruited.
Full Description
Primary Objective
To evaluate the feasibility of adding non-invasive sample collections in the pre-surgical setting and at the post-surgery follow-up visit.
To identify and assess metabolic and microbial signatures collected at pre- and post-surgery and determine which are indicative of lung cancer.
Secondary Objective
To identify signatures which are associated with lung cancer stage.
To identify signatures which are impacted by patient's pulmonary function status.
Eligibility Criteria
Inclusion Criteria:
Male and female patients age >18 years, of all racial and ethnic origins, with suspected nonsmall cell lung cancer stages I, II, and III, as evident through radiographic evidence and felt acceptable to undergo surgical resection.
Patients who have the ability to understand and the willingness to sign a written consent form.
Exclusion Criteria:
Patients who are have taken antibiotics within two weeks.
Patients who are on continuous supplemental oxygen.
Patients currently undergoing active treatment for other malignancies.
Subjects who are unable or unwilling to provide consent.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Winston-Salem North Carolina, 27157, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.